The non-sterile compounding pharmacy market is witnessing remarkable growth, driven by the increasing demand for personalized medicine and advances in pharmaceutical formulation techniques. Estimated at US$ 5.97 billion in 2024, it is projected to grow to US$ 6.41 billion in 2025 and reach approximately US$ 12.11 billion by 2034, expanding at a CAGR of 7.34% between 2025 and 2034.
With applications spanning dermatology, hormonal therapies, and beyond, compounded pharmaceuticals are reshaping patient care globally. Let’s dive into key trends, regional insights, and a spotlight on leading companies in the non-sterile compounding pharmacy market.
📈 Market Overview
-
Market Size (2024): US$ 5.97 Billion
-
Market Size (2025): US$ 6.41 Billion
-
Forecast (2034): US$ 12.11 Billion
-
CAGR (2025–2034): 7.34%
🔥 Key Drivers
-
Rising preference for customized medicines over commercial alternatives.
-
Growth in dermatology and hormonal replacement therapies.
-
Innovations in delivery systems for improved patient adherence.
🌍 Regional Insights
-
North America led with a market share of 48–52% in 2024.
-
Asia Pacific expected to post the fastest CAGR during 2025–2034.
💊 Segmental Insights
-
Oral Solids dominated with 35–38% market share in 2024.
-
Topicals are forecast to grow at the highest CAGR.
-
Hormonal Replacement Therapy (HRT) was the leading therapeutic area in 2024, contributing 30–35% revenue.
🌟 Top Companies in the Non-Sterile Compounding Pharmacy Market
Here’s a closer look at the major players shaping the non-sterile compounding pharmacy market, including their background, offerings, and market positioning.
1️⃣ Advanced Pharmacy
-
About: Based in Texas, Advanced Pharmacy is a leading compounding pharmacy offering personalized medications for pain management, dermatology, and veterinary needs.
-
Products: Oral solutions, creams, transdermal gels.
-
Market Cap: Estimated mid-size player with strong regional presence in North America.
2️⃣ Avella Specialty Pharmacy
-
About: Avella is renowned for its specialty and compounding services, with a focus on oncology, dermatology, and ophthalmology.
-
Products: Topical preparations, injectables, and hormone therapies.
-
Market Cap: Part of UnitedHealth Group after acquisition, contributing to a multibillion-dollar network.
3️⃣ BCP (Belmar Pharma Solutions)
-
About: BCP specializes in bioidentical hormone replacement therapy (BHRT) and custom compounding services across the U.S.
-
Products: Capsules, troches, topical creams.
-
Market Cap: Privately held, but among the top-tier compounding service providers.
4️⃣ CareFirst Specialty Pharmacy
-
About: Serving both humans and pets, CareFirst is known for its advanced compounding labs and quality control.
-
Products: Oral suspensions, suppositories, transdermal patches.
-
Market Cap: Emerging regional player with growing influence.
5️⃣ Central Compounding Center
-
About: Central Compounding Center caters to physicians and patients seeking high-quality custom formulations.
-
Products: Dermatology creams, hormone replacement capsules, veterinary compounds.
-
Market Cap: Small but rapidly expanding footprint in the Midwest U.S.
6️⃣ Cipla Medpro (Compounding Division)
-
About: A division of Cipla Limited, Cipla Medpro offers non-sterile compounding solutions in South Africa and beyond.
-
Products: Topical dermatological formulations, oral liquids.
-
Market Cap: Part of Cipla’s global valuation exceeding US$ 10 billion.
7️⃣ Clinigen Group
-
About: Clinigen provides unlicensed medicines and compounding services, addressing niche therapeutic needs.
-
Products: Custom oral and topical formulations.
-
Market Cap: Approx. £1 billion (private after acquisition by Triton).
8️⃣ Columbia Veterinary Pharmacy
-
About: Specializes in veterinary compounding, serving both small and large animals.
-
Products: Flavored oral suspensions, transdermal gels for pets.
-
Market Cap: Niche player with steady growth in veterinary segment.
9️⃣ Fagron
-
About: A global leader in pharmaceutical compounding with operations in over 30 countries.
-
Products: Dermatology creams, oral suspensions, personalized medicine kits.
-
Market Cap: Approx. €1.6 billion.
1️⃣0️⃣ Innovation Compounding
-
About: Focuses on wellness and anti-aging formulations alongside traditional compounding services.
-
Products: BHRT, dermatology, pediatric formulations.
-
Market Cap: Leading independent U.S. pharmacy.
1️⃣1️⃣ ITC Compounding Pharmacy
-
About: Known for hormone therapy and dermatological formulations tailored to individual patient needs.
-
Products: Oral capsules, topical gels, sublingual tablets.
-
Market Cap: Mid-size U.S. player with a strong patient base.
1️⃣2️⃣ Letco Medical
-
About: Supplies high-quality APIs and excipients for compounding pharmacies, alongside their own compounding services.
-
Products: Customizable non-sterile medication kits.
-
Market Cap: Significant supplier network in North America.
1️⃣3️⃣ Medisca
-
About: A global supplier of pharmaceutical compounding products and equipment.
-
Products: Oral solutions, dermatological creams, veterinary formulations.
-
Market Cap: Large-scale global operations, privately held.
1️⃣4️⃣ National Custom Compounding
-
About: Australian pharmacy specializing in customized medications for dermatology and sports medicine.
-
Products: Capsules, creams, oral liquids.
-
Market Cap: Prominent in Oceania’s compounding market.
1️⃣5️⃣ Pencol Compounding Pharmacy
-
About: Offers innovative compounding solutions focusing on patient-specific therapies.
-
Products: Transdermal creams, oral suspensions, pediatric formulations.
-
Market Cap: Small yet growing U.S. player.
1️⃣6️⃣ PCCA (Professional Compounding Centers of America)
-
About: PCCA is a global supplier supporting compounding pharmacies with ingredients, education, and training.
-
Products: APIs, excipients, equipment for pharmacies.
-
Market Cap: Integral to compounding infrastructure worldwide.
1️⃣7️⃣ PharmScript
-
About: Provides pharmacy services to long-term care facilities including non-sterile compounding.
-
Products: Oral tablets, topical solutions for institutional use.
-
Market Cap: Mid-size U.S. pharmacy with a focus on institutional healthcare.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
❓ FAQs About the Non-Sterile Compounding Pharmacy Market
Q1: What is driving the growth of the non-sterile compounding pharmacy market?
A1: Growing demand for personalized medicine, advancements in compounding technologies, and rising prevalence of chronic diseases.
Q2: Which region dominates the global market?
A2: North America held the largest market share in 2024, driven by advanced healthcare infrastructure and regulatory support.
Q3: Which dosage form leads the market?
A3: Oral solids accounted for the largest market share in 2024, while topicals are expected to grow fastest.
Q4: What are some emerging trends in this market?
A4: Increased use of automation in compounding, growth of veterinary compounding, and a focus on anti-aging formulations.
Q5: Who are the key players in the market?
A5: Major companies include Fagron, Medisca, PCCA, Avella Specialty Pharmacy, and Advanced Pharmacy.
Source : https://www.towardshealthcare.com/insights/non-sterile-compounding-pharmacy-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5864
About the Author
